Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | ANPEP | P15144 | 2/20 | 0.41 |
| ▸ | PDE4A | P27815 | 1/20 | 0.41 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.41 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL402028 | 1.00 | CA2 (0.43) | CA2CA1ANPEPPDE4APDE4B | |
| SCHEMBL405477 | 0.89 | CCR1 (0.47) | ANPEPPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL402851 | 0.89 | CCR1 (0.47) | ANPEPPDE4APDE4BPDE4CPDE4D | |
| SCHEMBL2873360 | 0.88 | CA2 (0.56) | CA2CA1ALDH1A1GAAPKM | |
| SCHEMBL403937 | 0.85 | TAS1R3 (0.51) | CA2CA1ALDH1A1GAAPKM | |
| SCHEMBL9902468 | 0.85 | TAS1R3 (0.51) | CA2CA1ALDH1A1GAAPKM | |
| SCHEMBL1109256 | 0.85 | TAS1R3 (0.51) | CA2CA1ALDH1A1GAAPKM | |
| SCHEMBL12055901 | 0.85 | NPC1 (0.48) | CA2CA1ALDH1A1 | |
| SCHEMBL12837671 | 0.83 | CA2 (0.43) | CA2CA1HDAC6ALDH1A1GAA | |
| SCHEMBL403958 | 0.83 | HDAC8 (0.55) | ANPEPPDE4APDE4BPDE4CPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1618087-B1 | ANTIBACTERIAL AGENTS | NOVARTIS VACCINES & DIAGNOSTIC (US) | 2012-06-13 | — | — | EP | disclosed |